发明名称 |
PHARMACEUTICAL COMPOSITIONS CONTAINING TSG-6 FOR TREATING INFLAMMATORY DISEASES AND CANCER-RELATED PATHOLOGIES AND METHODS |
摘要 |
Pleiotropic pro-inflammatory cytokines, such as TNF and IL-1, induce expression of a protein molecule, termed TSG-6, in connective tissue cells. TSG-6, or pharmaceutical compositions containing TSG-6, can be used to treat inflammatory diseases and disorders and cancer-related pathologies. Inflammatory diseases and disorders, or cancer-related pathologies, can also be treated by introducing human cells transfected with a DNA molecule containing a DNA segment encoding TSG-6 protein, into humans to express therapeutically effective amounts of TSG-6 in vivo or by introducing a vector carrying a DNA segment encoding TSG-6 protein directly into humans in vivo.
|
申请公布号 |
WO9704075(A1) |
申请公布日期 |
1997.02.06 |
申请号 |
WO1996US11995 |
申请日期 |
1996.07.19 |
申请人 |
NEW YORK UNIVERSITY;WISNIEWSKI, HANS-GEORG;VILCEK, JAN;CRONSTEIN, BRUCE, N. |
发明人 |
WISNIEWSKI, HANS-GEORG;VILCEK, JAN;CRONSTEIN, BRUCE, N. |
分类号 |
A61K38/00;C07K14/47;C07K14/81;(IPC1-7):C12N5/00;C12N15/00;A61K48/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|